Distant metastasis-free survival: the time which cancer does not spread to distant organs ... provide additional support for ...

Bicycle Therapeutics plc , a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that the ...

For our methodology, we used a stock screener and selected healthcare stocks that had an RSI below 30, mid-market cap, and ...

Presented Encouraging Phase 2 Data on NUC-7738 in Combination with Pembrolizumab at the European Society for Medical Oncology (ESMO) Congress ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.